Cerus Corporation

US$2.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CERSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (8.31%)
Div yield —
ROE (10.67%)
Medical Devices
Beta (5Y) 1.85
PE TTM —
TSR TTM 37.41%
Mkt cap US$407.9M
ROIC (0.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.40
18.85%
24.27%
Hold 0|5|11|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
10.07%
3.32%
18.63%
29.09%
Revenue$M
46.67
48.24
47.89
47.00
6.32%
5.89%
7.32%
(0.45%)
Peers (US$407.9M)
Cap (US$)
PE
436.5M
—
429.1M
—
Capital
TTM
5Y
10Y
Leveragex
1.356
(0.118)
(0.116)
EBIT/Intx
0.587
0.159
0.123
Own earn%
14.52
(305.36)
(262.93)
Sh yield%
36.33
15.94
22.25
Owners
Insiders/Inst%
8.24
52.19
Short interest%
3.80
SBC / revenue%
3.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
24–34
$1 testx
—
Incr. ROIC%
3